sec info  gl partners capital management ltd et al  ‘sc d’ on  re sciclone pharmaceuticals inc  filing submission sec info uses javascript  to view pages properly enable javascript in your browser     sec info      home      search      my interests      help      sign in      please sign in gl partners capital management ltd et al – ‘sc d’ on  re sciclone pharmaceuticals incon  monday  at pm et   ·   accession      ·   file    previous ‘sc d’  none   ·   next  ‘sc da’ on    ·   latest  ‘sc da’ on    in  this entire filing an entity search   show  docs searched  and  every hit the st hit help wildcards   any letter   many  logic  for docs   and   or  for text   anywhere   near    ↓bottom   t as of filer filing for·on·as docssize issuer agent  gl partners capital mgmt ltd sc d k sciclone pharmaceuticals inc merrill corp fajmsiifa gl capital management gp lp gl capital management gp ltd gl china opportunities fund lp gl trade investment ltd zhenfu lifgeneral statement of beneficial ownership   —   schedule dfiling table of contents documentexhibit description pages size  sc d general statement of beneficial ownership html k  ex miscellaneous exhibit html k filing submission  – sgml textraw sgmltagged text that was submitted by  merrill corp fajmsiifa  as filing agentshow all document text elements below                  ↑top ↓bottom  submission                                                                     acceptancedatetime  accessionnumber  type sc d publicdocumentcount  filingdate  dateoffilingdatechange  groupmembers gl capital management gp lp groupmembers gl capital management gp ltd groupmembers gl china opportunities fund lp groupmembers gl trade investment ltd groupmembers zhenfu li subjectcompany companydata conformedname sciclone pharmaceuticals inc cik  assignedsic  irsnumber  stateofincorporation de fiscalyearend  companydata filingvalues formtype sc d act  filenumber  filmnumber  filingvalues businessaddress street  tower lane street suite  city foster city state ca zip  phone  businessaddress mailaddress street  tower lane street suite  city foster city state ca zip  mailaddress subjectcompany filedby companydata conformedname gl partners capital management ltd cik  irsnumber  stateofincorporation e this is an secspecific code that maps to cayman islands  uk   zip  mailaddress filedby submission↑top filing submission    –   alternative formats word  rich text html plain text et al copyright   fran finnegan  company  all rights reservedabout – privacy – redactions – help — fri  jul  gmt  gl partners capital management ltd top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active gl partners capital management ltd • beijing f how do i update this listing gl partners capital management ltd is based out of beijing whalewisdom has at least  dg filings in our database for gl partners capital management ltd summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from gl partners capital management ltd enter your email address below and choose submit your email cancel contact info gl partners capital management ltd afglobal trademansion guanghua rd beijing f     business phone   recent sec filings sc da filed on  sc da filed on  sc da filed on   filed on  sc da filed on  sc da filed on  sc da filed on  sc da filed on  sc ga filed on  sc g filed on  current dg holdings stock sector shares held market value rank source source date sciccone pharmaceuticals inc scln health care    d  china biologic products inc cbpo health care    g  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free gl partners capital management ltd bizpediaxyz  we monitor changes in companies bizpediaxyz  we monitor changes in companies gl partners capital management ltd free email watchdog get free email notifications about news in gl partners capital management ltd the service is free and you can unsubscribe at any time general  filings  cik number  gl partners capital management ltd addressafglobal trademansion guanghua rdbeijing  earliest known filing november  latest known filing june  company filings sec filings are a great source of information for companies including investments company events and all sorts of other information gl partners capital management ltd has  filings view gl partners capital management ltd filings similar companiesglobal innovative investment group ltd global transport income fund master partnership scsp globekick llc global frontier life sciences opportunity fund i lp global bridge capital usd fund i lp glseq llc globalfoundries inc glance networks inc glassgannett spv llc glynn partners v lp globalflyte inc glendon opportunities fund ii lp global renewable power fund ii d lp global liquid markets llc glenrose avenue investors llc glassman andrew l glamst global financial private capital llc global education without limits llc global equity absolute return investors cayman ltd global wealth investments inc glickman matthew global indy i llc glade brook private investors x llc glenobey prospect partners global alpha international small cap fund lp global return value investments lp globechat inc glovista us feeder fund lp global synergy holdings inc glowb lights llc global allocation fund glorietta management group inc global sc finance iii ltd glimpse k inc global data solutions ltd glean tech fund lp glenmede private investment fund x llc gl chapel hill fund llc glen harbor capital management llc gln holdings inc glassbridge quant strategy onshore lp glassbridge quant strategy offshore ltd glca holdco ii llc glca holdco llc glass financial inc global infrastructure solutions inc global private alpha lp gll health sciences fund ltd global bridge capital inc bizpediaxyz collect news financial information sec filings stock information contact information personal information information about investments etc about gl partners capital management ltd gl partners capital management ltd  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors gl partners capital management ltd check out list of companies and businesses related to gl partners capital management ltd find out gl partners capital management ltd address and contact details view other people related to gl partners capital management ltd  coworkers colleagues companions etc address unit  china world tower  no  jian guo men wai avenue beijing  china companies related to gl partners capital management ltd cikcompany namepositioncompany addresssciclone pharmaceuticals inc tower lane suite  foster city  gl partners capital management ltd on the web persons related to gl partners capital management ltd  sciclone pharmaceuticals incnamepositioncityabg management ltdhong kongally bridge lb healthcare master fund ltdhong kongally bridge lb management ltdhong kongs p a aptafinromepeter barrettdirector cambridgepeter barrettdirector foster citypeter barrettdirector foster cityjohn d baxterjohn d baxterdirector san mateojohn d baxterdirector foster cityfriedhelm blobelpresident  ceo san mateofriedhelm blobelpresident  ceo foster cityfriedhelm blobelpresident  ceo foster cityedwin c cadmanedwin c cadmandirector san mateoroberto camerinidirector pomezia romeroberto camerinidirector foster cityroberto camerinidirector foster cityclaudio cavazza owner romeclaudio cavazza owner rome italyclaudio cavazza owner romeclaudio cavazza owner romepaolo cavazza owner luganopaolo cavazza owner luganopaolo cavazzaluganopaolo cavazza owner luganopaolo cavazza owner lugano switzerlandpaolo cavazza owner luganopaolo cavazza owner laganonancy t changdirector houstonnancy t changdirector foster citynancy t changdirector foster citychaumiere consultadoria  servicos sdc unipessoal lda funchal  madeiracarey cherngeneral counsel foster citywilson waishun cheungcfo  senior vp finance fremontwilson waishun cheungcfo  senior vp finance foster cityfarmaceutica lda defiantefunchal madeirafarmaceutica lda defiantemadeirafarmaceutica lda defiantemadeiradragon alpha lpbeijinggl capital management gp ltdbeijingjere e goyanjere e goyandirector san mateojie jackie guanfoster cityrichard j hawkinsdirector san mateorichard j hawkinsdirector foster cityrichard j hawkinsdirector foster cityrichard j hawkinsdirector foster cityrolf h henelrolf h heneldirector san mateorolf h heneldirector foster cityrolf h heneldirector foster cityivan huiprincipal accounting officer san mateoivan huiprincipal accounting officer foster cityjade park investments ltdbeijingtrevor m jonesdirector reigate surreytrevor m jonesdirector foster cityrobert kingsvp of prod devsupply chain foster cityanthony gregg lapointedirector foster cityanthony gregg lapointedirector gaithersburganthony gregg lapointedirector foster citygregg anthony lapointedirector union citygregg anthony lapointedirector gaithersburgira d lawrencedirector san mateoira d lawrencedirector foster cityira d lawrencedirector foster citybin lihong kongsimon lidirector foster citylanchu liubeijingmark lottershanghaimark lotterceo china operations shanghaimark lotterceo china operations foster cityraymond anthony lowvp finance  controller fremontraymond anthony lowvp finance  controller foster citychuncai menggen counsel  vp compliance shanghaichuncai menggen counsel  vp compliance foster cityisrael riossr vp medical affairs  cmo foster cityisrael rioschief medical officer foster cityisrael rioschief medical officer foster cityalfred r rudolphchief operating officer san mateojon s saxedirector jon s saxedirector foster cityjon s saxedirector foster cityjon s saxedirector san mateohans p schmidpres  mng dir sciclone intl san mateohans p schmidpres  mng dir sciclone intl foster cityhans p schmidpres  mng dir sciclone intl foster cityhans p schmidpres  mng dir sciclone intl foster citydonald r sellerspresident and ceo san mateotau finanziaria spa sigma owner rome italytau finanziaria spa sigma owner rometau finanziaria spa sigma owner rinetau finanziaria spa sigma owner rometau finanziaria spa sigma owner romesa sinafgary titussenior vp finance  cfo foster citygary titussenior vp finance  cfo foster citygary tituscfo  sr vp finance foster citywinnie wingkei tsofoster cityrichard a waldronevp  cfo san mateostephanie wongvp finance and controller foster citydean s woodmandean s woodmandirector san mateodean s woodmandirector san mateodean s woodmandirector foster citydean s woodmandirector foster citylan xievp finance china cfo foster citylan xievp finance china cfo foster citymin yinvp compliance  internal audit foster cityfan yuhong konghong zhaoceo china operations shanghaihong zhaoceo china operations foster city d filing gl partners capital management ltd and sciclone pharmaceuticals inc scln  insider monkey companies  see all hedge funds  see all insiders  see all institutional investors  see all click here to see all results for sorry no results has been found matching your query adblocker detected dear valued visitor we have noticed that you are using an ad blocker software although advertisements on the web pages may degrade your experience our business certainly depends on them and we can only keep providing you highquality research based articles as long as we can display ads on our pages to view this article you can disable your ad blocker and refresh this page or simply login we only allow registered users to use ad blockers you can sign up for free by clicking here or you can login if you are already a member hedge funds d filing gl partners capital management ltd and sciclone pharmaceuticals inc scln published on june   at  pm by insider monkey staff in hedge funds page  of next gtgt you can access the original sec filing by clicking here ownership summary table name sole voting power shared voting power sole dispositive power shared dispositive power aggregate amount owned power percent of class gl trade investment limited       gl china opportunities fund       gl capital management gp       gl capital management gp limited       gl partners capital management limited       zhenfu li       page  of  – sec filing   united states securities and exchange commission washington dc  schedule d   under the securities exchange act of amendment no  information to be included in statements filed pursuant to rule da and amendments thereto filed pursuant to rule da sciclone pharmaceuticals inc name of issuer  common stock par value us per share title of class of securities  k cusip number  ms shirley lin unit  china world tower  no jian guo men wai avenue beijing  people’s republic of china phone    name address and telephone number of person authorized to receive notices and communications  june   date of event which requires filing of this statement if the filing person has previously filed a statement on schedule g to report the acquisition that is the subject of this schedule d and is filing this schedule because of §§de df or dg check the following box ¨ note schedules filed in paper format shall include a signed original and five copies of the schedule including all exhibits see §d for other parties to whom copies are to be sent  the remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page the information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section  of the securities exchange act of  “act” or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act however see the notes follow sciclone pharmaceuticals inc nasdaqsclnfollow sciclone pharmaceuticals inc nasdaqscln trade nasdaqscln now page  of next gtgt related insider monkey articlesd filing horton capital partners llc and creative realities inc crexd filing gamco investors and cavco industries inc cvcod filing lone star value management and superior drilling products inc d filing red mountain capital and air transport services group inc atsgd filing marcato capital management and buffalo wild wings inc bwldd filing trian partners and wendy’s co wen nasdaqscln gl partners capital management ltd sciclone pharmaceuticals inc scln sec d filing insider monkey small cap strategy download a free copy of our newsletter and see the details inside hedge fund resource center how to beat the market by  percentage points why track hedge funds download a free edition why you should dump your hedge funds  things you didnt know about hedge funds billionaire hedge funds warren buffett berkshire hathaway  david einhorn greenlight capital  george soros soros fund management  t boone pickens bp capital  jim simons renaissance technologies  leon cooperman omega advisors  carl icahn icahn capital lp  steve cohen point asset management  john paulson paulson  co  david tepper appaloosa management lp  about us contact us terms of use privacy policy next post home hedge funds markets blog authors about us contact us privacy policy terms of use site map all text and design is copyright  koala guide llc all rights reserved ﻿ gl partners capital management ltd bought sciclone pharmaceuticals inc’s shares – octafinance friday  july  menu featured news  years ago  alphabet inc nasdaqgoogl tests its ad technology on billboards to cushion itself against ad blocks  years ago  china margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisis  years ago  marc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and gold  years ago  carl icahn criticizes the fed feels bad for investors buying junk bonds  years ago  john burbank european qe can’t save the markets same as the us quantitative easing everything will be liquidated gl partners capital management ltd bought sciclone pharmaceuticals inc’s shares  by octastaff in sec g  d filings share with your friendsyour nameyour emailrecipient emailenter a messagei read this article and found it very interesting thought it might be interesting for you the article is called gl partners capital management ltd bought sciclone pharmaceuticals inc’s shares and is was published by octafinancecom at httpwwwoctafinancecomglpartnerscapitalmanagementltdboughtsciclonepharmaceuticalsincssharescaptchasubmitgl partners capital management ltd increased position in sciclone pharmaceuticals inc nasdaqscln gl partners capital management ltd has filled a sc da form regarding sciclone pharmaceuticals inc    filing link  per gl partners capital management ltd’s filing the filler reported increased stake in the company by  to  shares gl partners capital management ltd now owns  of the health carecompany this form was required due to trading activity on august   sciclone pharmaceuticals inc hedge funds ownership latest sec filings show  hedge funds and institutional investors own sciclone pharmaceuticals inc the institutional ownership of the company in q  is high at  of the shares outstanding they decreased by  the total shares they hold as of that quarter these institutional investors owned  shares a total of  funds opened new positions in sciclone pharmaceuticals inc and  increased their holdings there were  funds that closed their positions and  that reduced them wilmot b harkey and daniel mack nantahala capital management llc is the most positive institutional investor on sciclone pharmaceuticals inc with ownership of  shares as of q  for  of the fund’s portfolio sensato investors llc is another positive player owning  shares of the company or  of their stocks portfolio al rfg advisory group llc have  of their stock portfolio invested in the stock for  further ativo capital management llc disclosed it had purchased a stake worth  of the fund’s stock portfolio in the company the tx ranger investment management lp was also a notable investor in the firm owning  shares sciclone pharmaceuticals inc is  of the fund’s stock portfolio company profile sciclone pharmaceuticals inc sciclone is a pharmaceutical company the company operates in two geographic segments including china and the rest of the world the united states and hong kong the company’s lead product zadaxin thymalfasin is used for the treatment of hepatitis b virus hbv hepatitis c hcv as a vaccine adjuvant and certain cancers its development portfolio includes angiomax an anticoagulant indicated in patients undergoing percutaneous coronary intervention pci neucardin therapeutic drug for the treatment of patients with intermediate to advanced chronic heart failure chf loramyc a mucoadhesive tablet formulation of miconazole lauriad to treat oropharyngeal candidiasis cleviprex a thirdgeneration dihydropyridine calcium channel blocker for the reduction of blood pressure proflow to treat peripheral arterial disease pad and other indications and rapidfilm an oral film formulation of ondansetron to treat nausea induced by chemotherapy form d is sec filing that must be submitted within  days by anyone who acquires beneficial ownership of more than  of any publicly traded securities a filer must promptly update its d filing in case of acquisition or disposition of  or more of the securities that are the subject of the filing these filings may be a precursor to hostile takeovers company breakups and other “change of control” events receive news  ratings via email  enter your email address below to receive a concise daily summary of the latest news and analysts ratings with marketbeatcoms free daily email newsletter tagged nasdaqscln shipbob i fund a series of wefunds filing michael norman filed aug  form pittenger  anderson inc just filed its q  stock holdings free email newsletter enter your email address below to get the latest news and analysts ratings for your stocks with our free daily email newsletter hedge fund newstop  citadel advisors f holdings in q df dent  co inc just released its q  stock positionsmaverick capital top  holdings in q analyzing ken griffins citadel advisors stock holdings in q lone pine capital top  f positions in q guru newsfelix zulauf sees a stock market correction coming this rally sp  indexspinx will be shortlivedmarc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and goldjim grant the next thing might be helicopter money what to buy and where he sees investment opportunitieskyle bass bearish on emerging markets for at least  more years looking to short currenciesdavid tepper gets defensive is it time to get out of the stock market macro newschina margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisisare us – russian relations a zerosum gameus and russia have launched direct talks on the conflict in syriayuan drops as pboc cuts reference rate by most since devaluationcould the market crash like —put volume spike argues low is nearctas newsred rock just published report about the trend following landscape  how ctas’ performance must be analyzedhow to implement dual momentum for nonus investorsdo commodity trading advisors ctas really provide crisis alpha equity hedge and are long volatility the weekly hub trending business privacy policy contact latest headlines atlantica yield plc aby analysts see  eps dolores ford wall street await atlantica yield plc nasdaqaby to release earnings on august  analysts forecast earnings per share of  up exactly  or   from ’s  eps the expected aby’s profit could reach m giving the stock  pe in the case that  earnings per share is reported  arbor realty trust inc abr eps estimated at  zillow group inc zg analysts see  eps  eps expected for zafgen inc zfgn olympic steel inc zeus analysts see  eps zendesk inc zen analysts see  eps zillow group inc z eps estimated at  analysts see  eps for yum brands inc yum yrc worldwide inc yrcw eps estimated at  ypf sa adr ypf analysts see  eps  eps expected for alleghany corporation y  eps expected for acceleron pharma inc xlrn wyndham worldwide corporation wyn analysts see  eps eps for the western union company wu expected at  analysts see  eps for weight watchers international inc wtw  eps expected for wt offshore inc wti recent posts atlantica yield plc aby analysts see  eps arbor realty trust inc abr eps estimated at  zillow group inc zg analysts see  eps  eps expected for zafgen inc zfgn olympic steel inc zeus analysts see  eps zendesk inc zen analysts see  eps zillow group inc z eps estimated at  analysts see  eps for yum brands inc yum yrc worldwide inc yrcw eps estimated at  ypf sa adr ypf analysts see  eps get the next big winner in your inbox before the bell listsconsumer eagle twitter auto publish powered by  xyzscriptscom new york state teachers retirement system cuts position in sciclone pharmaceuticals inc scln  daily political home aboutcontact columnists privacy policy headlines politics nation world issues economy finance sciclone pharmaceuticals inc  get news  ratings daily enter your email address below to get the latest news and analysts ratings for sciclone pharmaceuticals inc with our free daily email newsletter follow dailypolitical     latest news ofg bancorp nyseofg position maintained by new york state teachers retirement system new york state teachers retirement system cuts position in sciclone pharmaceuticals inc scln new york state teachers retirement system sells  shares of avis budget group inc nasdaqcar new york state teachers retirement system holds stake in nanometrics incorporated nasdaqnano piper jaffray companies pjc shares bought by renaissance technologies llc renaissance technologies llc sells  shares of big  sporting goods corporation nasdaqbgfv renaissance technologies llc invests  million in international paper company ip us capital advisors comments on gulfport energy corporation’s q  earnings nasdaqgpor mersana therpts nasdaqmrsn expected to post q  earnings of  per share research analysts set expectations for oge energy corporation’s q  earnings nyseoge assa abloy ab otcmktsasazy rating increased to buy at zacks investment research tmx group limited’s tsex sector perform rating reaffirmed at scotiabank jamieson wellness inc jwel earns outperform rating from cibc prairiesky royalty ltd tsepsk given new c price target at gmp securities kcg holdings inc sells  shares of american financial group inc afg kcg holdings inc cuts position in fortinet inc nasdaqftnt amalgamated bank buys shares of  pacira pharmaceuticals inc nasdaqpcrx united capital financial advisers llc reduces stake in paypal holdings inc pypl santander consumer usa holdings inc sc stake increased by amalgamated bank amalgamated bank has  stake in rambus inc nasdaqrmbs new york state teachers retirement system cuts position in sciclone pharmaceuticals inc scln july th    comments  filed under  by trevor kearing filed under finance  sec filing articles tweet new york state teachers retirement system lowered its position in shares of sciclone pharmaceuticals inc nasdaqscln by  during the first quarter according to its most recent form f filing with the sec the institutional investor owned  shares of the specialty pharmaceutical company’s stock after selling  shares during the period new york state teachers retirement system owned approximately  of sciclone pharmaceuticals worth  as of its most recent sec filing other hedge funds have also made changes to their positions in the company ls investment advisors llc boosted its stake in shares of sciclone pharmaceuticals by  in the first quarter ls investment advisors llc now owns  shares of the specialty pharmaceutical company’s stock worth  after buying an additional  shares in the last quarter bnp paribas arbitrage sa boosted its stake in shares of sciclone pharmaceuticals by  in the first quarter bnp paribas arbitrage sa now owns  shares of the specialty pharmaceutical company’s stock worth  after buying an additional  shares during the period municipal employees retirement system of michigan boosted its stake in shares of sciclone pharmaceuticals by  in the first quarter municipal employees retirement system of michigan now owns  shares of the specialty pharmaceutical company’s stock worth  after buying an additional  shares during the period mason street advisors llc boosted its stake in shares of sciclone pharmaceuticals by  in the first quarter mason street advisors llc now owns  shares of the specialty pharmaceutical company’s stock worth  after buying an additional  shares during the period finally oppenheimerfunds inc boosted its stake in shares of sciclone pharmaceuticals by  in the first quarter oppenheimerfunds inc now owns  shares of the specialty pharmaceutical company’s stock worth  after buying an additional  shares during the period  of the stock is owned by institutional investors and hedge funds shares of sciclone pharmaceuticals inc scln opened at  on friday the stock has a  day moving average of  and a day moving average of  sciclone pharmaceuticals inc has a  week low of  and a  week high of  the stock has a market capitalization of  million a pe ratio of  and a beta of  trademark violation notice this story was first posted by daily political and is the property of of daily political if you are accessing this story on another website it was illegally stolen and republished in violation of united states and international trademark and copyright law the legal version of this story can be accessed at httpswwwdailypoliticalcomnewyorkstateteachersretirementsystemcutspositioninsciclonepharmaceuticalsincsclnhtml separately maxim group set a  price objective on shares of sciclone pharmaceuticals and gave the stock a “buy” rating in a research note on thursday may th in related news ceo friedhelm blobel sold  shares of the business’s stock in a transaction on friday june th the shares were sold at an average price of  for a total value of  following the completion of the transaction the chief executive officer now directly owns  shares in the company valued at approximately  the transaction was disclosed in a document filed with the sec which is accessible through the sec website also cfo wilson waishun cheung sold  shares of the business’s stock in a transaction on monday june th the shares were sold at an average price of  for a total transaction of  following the completion of the transaction the chief financial officer now owns  shares of the company’s stock valued at  the disclosure for this sale can be found here over the last quarter insiders sold  shares of company stock valued at  company insiders own  of the company’s stock about sciclone pharmaceuticals sciclone pharmaceuticals inc is a pharmaceutical company the company’s product portfolio of therapies includes oncology infectious diseases and cardiovascular disorders the company’s business is focused primarily in the people’s republic of china the company operates in two segments china and the rest of the world including its operations in the united states and hong kong receive news  ratings for sciclone pharmaceuticals inc daily  enter your email address below to receive a concise daily summary of the latest news and analysts ratings for sciclone pharmaceuticals inc and related companies with marketbeatcoms free daily email newsletter  comment on this post click here to cancel reply name required mail will not be published required website wordpress hashcash needs javascript to work but your browser has javascript disabled your comment will be placed in moderation latest news jeff sessions spoke of resigning after tensions increase with trump president trump’s tweets complicate already complicated week world leaders very critical of paris agreement decision by trump aide to president trump resigns with more expected scudclass missile launched by north korea  dailypolitical llc  all rights reserved privacy policy  about  columnists  contact gl partners capital management ltd  sciclone pharmaceuticals insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailsgl partners capital management ltdsciclone pharmaceuticals sclnten percent owner not rankedgl partners capital management ltds performancegl partners capital management ltd has not reported any informative transactions and therefore cannot be rankedhow are insiders ranked insider holdings  sciclone pharmaceuticals sclnmsee the top stocks by insiders  insider rolessciclone pharmaceuticals scln ten percent ownersee the top  corporate insiders  most profitable insider tradestock sciclone pharmaceuticals sclntransaction type informative buydates feb    feb  gain see the latest stocks traded by insiders  gl partners capital management ltds trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction datesclnsciclone pharmaceuticalsten percent ownerinformative buyundisclosedfeb  gl partners capital management ltd has not reported any informative transactions for scln therefore performance cannot be measured track record datetransactionamountno of sharesprice per shareprofitform  feb   informative buy undisclosed   na see all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by secgems gl partners capital management ltd data feeds now available excel  csv  java  python etc database learn more gl partners capital management ltd info ownership filings  ←  → filings    of   total  june    filed by gl partners capital management ltd subject company sciclone pharmaceuticals inc group member gl capital management gp lp gl capital management gp ltd gl china opportunities fund lp gl trade investment ltd zhenfu li preview view filing  sc da nc acquisition of beneficial ownership of  or more of any class of equity securities includes buy  acquire  sell  dispose  or more incl takeovers change of control feb    filed by gl partners capital management ltd subject company sciclone pharmaceuticals inc group member gl capital management gp lp gl capital management gp ltd gl china opportunities fund lp gl trade investment ltd zhenfu li preview view filing  sc da nc acquisition of beneficial ownership of  or more of any class of equity securities includes buy  acquire  sell  dispose  or more incl takeovers change of control nov    filed by gl partners capital management ltd subject company sciclone pharmaceuticals inc group member gl capital management gp lp gl capital management gp ltd gl china opportunities fund lp gl trade investment ltd zhenfu li preview view filing  sc da nc acquisition of beneficial ownership of  or more of any class of equity securities includes buy  acquire  sell  dispose  or more incl takeovers change of control feb    issuer sciclone pharmaceuticals inc scln reporting owner gl partners capital management ltd   owner  gl capital management gp ltd   owner  signed by gl partners capital management limited by li zhenfu director gl capital management gp limited by li zhenfu director preview view filing   nc xml  ownership initial statement of beneficial ownership of securities insider trading  directors officers significant shareholders  period ending feb   common stock par value  per share total owned   see footnote  feb    filed by gl partners capital management ltd subject company sciclone pharmaceuticals inc group member gl capital management gp lp gl capital management gp ltd gl china opportunities fund lp gl trade investment ltd zhenfu li preview view filing  sc da nc acquisition of beneficial ownership of  or more of any class of equity securities includes buy  acquire  sell  dispose  or more incl takeovers change of control feb    filed by gl partners capital management ltd subject company sciclone pharmaceuticals inc group member gl capital management gp lp gl capital management gp ltd gl china opportunities fund lp gl trade investment ltd zhenfu li preview view filing  sc da nc acquisition of beneficial ownership of  or more of any class of equity securities includes buy  acquire  sell  dispose  or more incl takeovers change of control aug    filed by gl partners capital management ltd subject company sciclone pharmaceuticals inc group member gl capital management gp lp gl capital management gp ltd gl china opportunities fund lp gl trade investment ltd zhenfu li preview view filing  sc da nc acquisition of beneficial ownership of  or more of any class of equity securities includes buy  acquire  sell  dispose  or more incl takeovers change of control aug    filed by gl partners capital management ltd subject company sciclone pharmaceuticals inc group member gl capital management gp lp gl capital management gp ltd gl china opportunities fund lp gl trade investment ltd zhenfu li preview view filing  sc da nc acquisition of beneficial ownership of  or more of any class of equity securities includes buy  acquire  sell  dispose  or more incl takeovers change of control feb    filed by gl partners capital management ltd subject company china biologic products inc group member gl capital management gp lp gl capital management gp ltd gl china opportunities fund lp gl trade investment ltd zhenfu li preview view filing  sc ga nc schedule filed to report acquisition of beneficial ownership of  or more of a class of equity securities by passive investors and institutions nov    filed by gl partners capital management ltd subject company sciclone pharmaceuticals inc group member gl capital management gp lp gl capital management gp ltd gl china opportunities fund lp gl trade investment ltd zhenfu li preview view filing  sc da nc acquisition of beneficial ownership of  or more of any class of equity securities includes buy  acquire  sell  dispose  or more incl takeovers change of control nov    filed by gl partners capital management ltd subject company china biologic products inc group member gl capital management gp lp gl capital management gp ltd gl china opportunities fund lp gl trade investment ltd zhenfu li preview view filing  sc g nc schedule filed to report acquisition of beneficial ownership of  or more of a class of equity securities by passive investors and institutions nov    filed by gl partners capital management ltd subject company sciclone pharmaceuticals inc group member gl capital management gp lp gl capital management gp ltd gl china opportunities fund lp gl trade investment ltd zhenfu li preview view filing  sc d nc acquisition of beneficial ownership of  or more of any class of equity securities includes buy  acquire  sell  dispose  or more incl takeovers change of control db